Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P Recall
Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P
FDA recall Class II
Ongoing
FDA lists this Class II recall for Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2260-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 10, 2026
- FDA report date
- Jun 3, 2026
- Quantity in commerce
- 8 kits
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P
Affected model & UDI checker
Search the exact identifiers published for Z-2260-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P | Check source notice | 10198459151569 |
| Not specified | Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P | Check source notice | 40198459151560 |
FDA code information
UDI/DI 10198459151569 (each), 40198459151560 (case), Lot Numbers: 26BMC538
Why was this product recalled?
Specific Medline Kits contain Cardinal Health Monoject 1mL Luer Lock Syringes, Tuberculin Print, Sterile. Cardinal Health has recalled these syringes because the outer carton and blister pack are labeled as a 1 mL Luer Lock Tuberculin Syringe (Product Code 1180100777), but the syringes inside are U-100 insulin syringes.
What actions did Medline Industries, LP take?
Medline Industries, LP issued an URGENT MEDICAL DEVICE RECALL notice to it consignees on 4/10/2026 via USPS first class mail and email. The notice explained the issue, potential risk, and requested the following: "REQUIRED ACTION: 1. Immediately check your stock for the affected item number(s) and the affected lot number(s) listed on the enclosed response form. Quarantine all affected product. 2. Please complete and return the enclosed response form listing the quantity of affected product you have in inventory. Even if you do not have any affected product in inventory, please complete and return the response form. 3. Upon receipt of your submitted response form, your account will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. 4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product." For questions, contact the Recall Department at 866-359-1704 or [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2260-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology